New
Elucid mHealth
The AI engine Fit Assessment
BetaElucid mHealth develops digital solutions for medication adherence monitoring and operates within the pharmaceutical industry, while also collecting real-time data from clinical trial participants.
Blurb
Elucid mHealth provide real-time remote monitoring tools for non-adherence and patient engagment within clinical trials.
HQ Location
Manchester (United Kingdom)
Founded
2013
Employees
1 - 10
Total funding raised
$1.89M
Funding Status
Series A, $1.89M, September 19, 2017
Subspaces
- Clinical Trial Data Collection
Elucid mHealth is a medication technology company creating adherence monitoring tools and virtual health platform aimed at improving clinical trial efficiencies.
Elucid's novel product, Pill Connect, provides trial organizers with real-time adherence data and missed dose prevention, new dose data, protocol control, engagement measurements and automated dose reconciliation.